Kezar Life Sciences Inc. (KZR): P/S multiplikatori

Kezar Life Sciences, Inc (KZR) brendining ramzi va logotipi

Kezar Life Sciences avtoimmun patologiyalarga qarshi kurashish uchun mo‘ljallangan proteasoma inhibitorlarini o‘z ichiga olgan immunoterapiyalarni ishlab chiqish orqali daromad keltiradi. Joriy P/S koeffitsiyenti bozor tebranishlarini aks ettiradi, bunda 7.70 qiymati joriy baholash darajasini tavsiflaydi. Oqsillarni bloklash usullariga tegishli intellektual mulk biznesni nusxalashdan himoya qiladi, ammo yuqori R&D xarajatlari va testlarning qayta ko‘rib chiqilishi kompaniyaning kengayish imkoniyatlarini vaqtincha cheklamoqda.

KZR Kezar Life Sciences Inc Kapitalizatsiyaning daromadga nisbati (15.11.2023 - 13.11.2024)

Kezar Life Sciences (KZR) kompaniyasi koʻrsatkichlari kesimi va tahlili

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Kompaniyaning jamlanma tahliliyoti:Kezar Life Sciences Inc., KZR
Kezar Life Sciences Inc brend mahsuloti

Kezar Life Sciences (KZR) kompaniyasining fundamental barqarorligini bozor shovqinlaridan ajratish uchun bozor kapitalizatsiyasining yillik daromadga nisbatini baholash juda muhimdir. Ushbu koeffitsient daromadning har bir dollari uchun xarajatni belgilab, investorlarga aktiv haddan tashqari sotib olingan yoki qadrsizlanganligini baholash imkonini beradi. Sotuvlarga nisbatan narx tendentsiyasi biznesning Fed ning qat'iy pul-kredit siyosatiga moslashishini aks ettiradi. Kompaniyaga tegishli immuno-onkologiya sohasidagi yuqori nufuz va noyob lupus terapiyasi usullari ushbu aylanmaning uzoq muddatli qiymatini ta'minlaydi.

Kezar Life Sciences raqobatchilari

argenx - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (biontech.de)|Abivax Corp (ABVX) - Sotuvga nisbatan narx|ADMA Corp - P/S multiplikatori|Narxning sotuvga nisbati PTGX|Immunovant Inc (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols Biemat) - P/S multiplikatori|P/S multiplikatori Adaptive Biotechnologies Inc.|Narxning daromadga nisbati Celldex Therapeutics (CLDX)|Narx/daromad koeffitsiyenti auriniapharma.com|Narxning daromadga nisbati BioCryst Pharmaceuticals BCRX|Bozor kapitallashuvining daromadga nisbati VERA|Dianthus Pharma - P/S multiplikatori|PHVS - P/S multiplikatori|ABCL: P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati Intrexon|PHAR - Narx/daromad multiplikatori|P/S multiplikatori NKTR|Narxning daromadga nisbati UPB (Upstream Bio Corp)|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Narx/daromad koeffitsiyenti immunome.com (IMNM)|Gossamer Bio Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati KALV (KalVista Pharmaceuticals, Inc.)|SEPN: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pieris Pharmaceuticals Inc|Kapitalizatsiyaning daromadga nisbati SVRA|Kapitalizatsiyaning daromadga nisbati Rigel Pharmaceuticals (RIGL)|P/S multiplikatori ANAB|ATXS - Sotuvga nisbatan narx|Narxning daromadga nisbati enGene Corp ENGN|Narx/daromad koeffitsiyenti RAPT Therapeutics, Inc. (RAPT)|Aerovate - P/S multiplikatori|ACRS - P/S multiplikatori|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx Tiziana Life Sciences Ltd. (TLSA)|Kapitalizatsiyaning daromadga nisbati CABA|Ventyx Biosciences (VTYX) - Narx/daromad koeffitsiyenti|P/S multiplikatori THTX|AVTX (Avalo Therapeutics, Inc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ELDN (eledon.com)|AGEN - Kapitalizatsiyaning daromadga nisbati|CLYM - Narxning daromadga nisbati|Narxning sotuvga nisbati ZURA|ATYR: P/S multiplikatori|Adagene Corp (ADAG) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati IMA|Shattuck Labs, Inc. - Narxning sotuvga nisbati|Narxning daromadga nisbati Equillium Inc (EQ)|P/S multiplikatori Connect Biopharma Holdings (CNTB)|Narxning daromadga nisbati Immunic, Inc. IMUX|P/S multiplikatori Atara Biotherapeutics ATRA|IFRX - Narxning daromadga nisbati|XFOR: Narxning daromadga nisbati|ACET: P/S multiplikatori|CELU - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati inmunebio.com|Kapitalizatsiya va daromad nisbati BRNS (barinthusbio.com)|P/S multiplikatori SABS|AKTX (Akari Therapeutics Plc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Narxning daromadga nisbati|GOVX: Kapitalizatsiyaning daromadga nisbati|edesabiotech.com (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|CARM - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati XTLB|Kapitalizatsiyaning daromadga nisbati boltbio.com (BOLT)|Narxning daromadga nisbati HCW Biologics Inc (HCWB)|P/S multiplikatori Aptevo Therapeutics, Inc. (APVO)|Narxning daromadga nisbati aimimmuno.com AIM|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio Corporation - P/S multiplikatori|XORTX Corp (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (Vyome Holdings Inc.) - Kapitalizatsiyaning daromadga nisbati|revbiosciences.com (REVB) - P/S multiplikatori|INDP (Indaptus Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Scinai Immunotherapeutics Ltd (SCNI)|Narxning daromadga nisbati CalciMedica Inc (CALI)|AFMD (Affimed NV) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos Inc.)|P/S multiplikatori HOOKIPA HOOK|IGMS: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iTeos)|OCEA: P/S multiplikatori|TCBP (TC BioPharm Ltd) - Narxning daromadga nisbati|THRD (Third Harmonic Bio Inc) - P/S multiplikatori